Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Procter & Gamble Health stock

PGHL.NS
INE199A01012

Price

5,625.00
Today +/-
-0.43
Today %
-0.68 %

Procter & Gamble Health stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Procter & Gamble Health stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Procter & Gamble Health stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Procter & Gamble Health stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Procter & Gamble Health's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Procter & Gamble Health Stock Price History

DateProcter & Gamble Health Price
12/16/20245,625.00 undefined
12/13/20245,663.15 undefined
12/12/20245,703.35 undefined
12/11/20245,630.00 undefined
12/10/20245,610.00 undefined
12/9/20245,640.10 undefined
12/6/20245,520.70 undefined
12/5/20245,599.60 undefined
12/4/20245,350.00 undefined
12/3/20245,280.05 undefined
12/2/20245,151.00 undefined
11/29/20245,191.00 undefined
11/28/20245,168.55 undefined
11/27/20245,206.65 undefined
11/26/20245,298.95 undefined
11/25/20245,159.10 undefined
11/22/20245,094.80 undefined
11/21/20245,119.60 undefined
11/19/20245,143.15 undefined
11/18/20245,116.65 undefined

Procter & Gamble Health Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Procter & Gamble Health, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Procter & Gamble Health from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Procter & Gamble Health’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Procter & Gamble Health. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Procter & Gamble Health’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Procter & Gamble Health’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Procter & Gamble Health’s growth potential.

Procter & Gamble Health Revenue, EBIT and net profit per share

DateProcter & Gamble Health RevenueProcter & Gamble Health EBITProcter & Gamble Health Net Income
202411.51 B undefined2.82 B undefined2.01 B undefined
202312.3 B undefined3.09 B undefined2.29 B undefined
202211.14 B undefined2.47 B undefined1.93 B undefined
202110.09 B undefined2.17 B undefined1.77 B undefined
202013.56 B undefined2.9 B undefined2.54 B undefined
201911.55 B undefined2.41 B undefined2.05 B undefined
20188.49 B undefined1.26 B undefined8.39 B undefined
20177.12 B undefined752 M undefined939 M undefined
201610.3 B undefined994 M undefined791 M undefined
20159.4 B undefined613 M undefined536 M undefined
20148.68 B undefined463 M undefined432 M undefined
20137.98 B undefined669 M undefined559 M undefined
20126.87 B undefined967 M undefined784 M undefined
20115.9 B undefined647 M undefined637 M undefined
20105.12 B undefined697 M undefined632 M undefined
20094.73 B undefined533 M undefined655 M undefined
20083.9 B undefined440 M undefined630 M undefined
20073.15 B undefined604 M undefined688 M undefined
20063.3 B undefined-15 M undefined1.33 B undefined
20053.97 B undefined699 M undefined788 M undefined

Procter & Gamble Health Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)NET INCOME (B)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
1997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024
2.592.592.783.133.393.473.643.773.973.33.153.94.735.125.96.877.988.689.410.37.128.4911.5513.5610.0911.1412.311.51
--7.2912.738.012.425.053.405.28-16.90-4.4623.7321.468.2415.1316.5716.088.748.309.61-30.9119.3336.0117.42-25.6110.4810.34-6.38
48.3248.3248.3548.1850.0451.3451.6554.2854.6857.7259.1254.7152.1555.2253.3652.8347.2446.8947.9651.6256.3560.6667.0860.5265.8163.1364.6865.24
1.251.251.341.511.691.781.882.042.171.91.862.132.472.833.153.633.774.074.515.324.015.157.758.216.647.047.957.51
0.270.270.180.390.450.40.40.710.791.330.690.630.660.630.640.780.560.430.540.790.948.392.052.541.771.932.292.01
---32.96112.7116.10-10.51-1.0079.2910.9969.29-48.43-8.433.97-3.510.7923.08-28.70-22.7224.0747.5718.71793.18-75.5323.83-30.428.8819.17-12.42
----------------------------
----------------------------
1717171717171717171717171717171717171717171716.617171716.616.6
----------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Procter & Gamble Health Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Procter & Gamble Health is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B)RECEIVABLES (B)OTHER REC. (B)INVENTORIES (B)OTHER CURRENT LIAB. (M)CURRENT ASSETS (B)TANGIBLE ASSETS (B)LONG-T. INVEST. (B)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (B)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (B)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (B)PROVISIONS (M)OTHER SHORT-TERM LIAB. (B)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (B)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (B)TOTAL CAPITAL (B)
19981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                                   
0.020.020.010.020.180.310.460.841.061.171.853.251.431.352.152.111.872.43.183.6212.435.736.364.693.324.48
0.30.320.390.380.420.520.490.570.280.310.010.010.010.620.640.841.051.211.071.230.660.770.950.590.831.16
0.120.120.160.140.140.110.150.150.190.30.590.661.20.650.440.260.240-0-00.2700.050.080.020.85
0.530.570.540.470.610.410.380.420.360.360.730.590.611.131.311.531.781.741.741.731.151.141.361.21.181.41
0000000001127030130050374359297374943838816.4184671378963.4
0.971.031.111.341.351.481.981.892.153.454.83.553.794.594.784.995.646.367.5215.348.459.567.276.147.96
0.640.650.720.670.60.560.440.410.370.40.620.640.510.720.770.941.371.391.411.231.171.091.191.41.51.73
0000.350.270.731.251.412.482.341.530.240.200000000.040.120.030.030.030.02
000000000000048358927322259468373949816.9581137986982.2
1188122121563634333433213212843.372109.4
00000000000000000000000000
00000.14000000.030.040.05000.490.50.160.340.410.990.190.891.020.290.3
0.650.650.811.151.121.341.721.862.882.752.190.920.771.21.361.712.12.142.432.392.252.212.22.592.83.05
1.611.681.912.152.462.693.213.834.784.95.645.724.3255.946.487.087.788.799.9117.5910.6711.769.868.9411.01
                                                   
169169169169169169169169169169169166166166166166166166166166166165.99166166166166
1111111111111111111111111111111111111111111111111111111111111110111111111111.3
0.670.771.041.231.481.682.22.73.653.954.234.43.193.824.564.955.275.736.367.0615.1288.796.765.897.23
000000000000000000000000083.6
00000000000000000000000000
0.951.051.321.511.761.962.482.983.934.234.514.673.464.14.845.235.546.016.647.3315.48.179.067.046.177.59
0.250.240.220.170.180.20.190.290.190.20.40.350.540.290.410.370.440.660.750.830.910.871.241.291.762.37
14915317223423927825401825454852259269160128723573390182163269353.1
0.070.10.130.140.130.160.220.490.550.360.570.580.220.220.290.60.790.781.081.351.011.350.850.890.30.28
91522135777324243345411210000000000000
00000000000000000000000482831.2
0.470.510.550.560.610.720.70.820.80.621.070.990.840.770.971.121.351.51.872.251.962.232.272.392.363.04
189123460000000000000000000029088.8
0008698132325464858651587110000000000
0000000000000122128122187271290327233273.44421406414375.2
1891234686981323254648586515130135133187271290327233273.44421435414464
0.660.630.590.650.70.730.730.850.850.671.131.050.850.91.111.251.541.782.162.582.192.52.72.832.773.5
1.611.681.912.152.462.693.213.834.784.95.645.734.3255.946.487.087.798.799.9117.610.6711.769.868.9411.1
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Procter & Gamble Health provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Procter & Gamble Health's financial health and stability.

Assets

Procter & Gamble Health's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Procter & Gamble Health must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Procter & Gamble Health after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Procter & Gamble Health's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (B)NET CASH FLOW FROM OPERATING ACTIVITIES (B)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (B)CASH FLOW FROM OTHER INVESTING ACTIVITIES (B)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (B)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
19981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
0.360.280.520.630.640.941.091.171.0410.920.960.960.961.170.880.670.831.151.5211.382.343.552.332.533.14
6982729410096867764655775717989100126234248264249171294300270281
00000000000000000000000000
-142-184-193-104-525-329-356-470-234-435-665-360-325-583-542-907-827-161-230-1,073-3,542-597-1,073-155-1,111-1,197
214219-21-14-10-82-95-210-248-270-262-42-263-172-7184-71-99-175-9,386-298-416-42133
45382353630000000000000000000
0.080.110.160.130.210.250.440.360.370.430.380.320.390.30.40.40.340.320.530.63.040.651.020.680.640.9
0.30.230.420.60.20.690.730.680.660.380.040.420.660.190.5400.050.831.070.54-1.31.622.352.471.72.36
-110-102-231-94-33-14-40-55-50-71-293-95-87-150-136-334-403-451-316-303-267-106-232-525-379-424
-0.1-0.09-0.23-0.430.08-0.41-0.39-0.11-0.150.210.160.021.76-0.09-0.820.070.11-0.68-0.75-0.4812.71.651.65-0.32-0.26-0.22
0.010.010-0.330.12-0.4-0.35-0.06-0.10.280.450.111.850.06-0.680.40.51-0.23-0.43-0.1712.961.761.880.20.120.21
00000000000000000000000000
-166-66-77-450000000000000000000-48-47-46
00000000000-107-10000000000000
-225-135-202-165-129-148-189-190-287-575-196-452-2,21900-48-166-119-149-219-300-8,794-8,834-3,866-2,886-984
-5.00-6.00-13.00-11.00-12.00-16.00-21.00-22.00-35.00-71.00-28.00-50.00-318.00---6.00-24.00-19.00-25.00-37.00-51.00-1,501.00-1,501.00---
-53-62-112-108-117-131-168-168-251-504-168-294-1,89900-41-142-99-124-182-249-7,292-7,332-3,817-2,838-937
-0.020-0.010.010.150.130.150.380.220.020-0.020.20.1-0.280.03-0.010.040.17-0.1611.09-5.52-4.83-1.72-1.451.16
194.7122.3191.1507.3168.5677.9692.9628.7610.5309.9-254.5321.9571.837.3406.5-329.6-354.3382.8753.9233.6-1,5711,512.482,1211,946.81,316.11,935.1
00000000000000000000000000

Procter & Gamble Health stock margins

The Procter & Gamble Health margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Procter & Gamble Health. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Procter & Gamble Health.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Procter & Gamble Health's sales revenue. A higher gross margin percentage indicates that the Procter & Gamble Health retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Procter & Gamble Health's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Procter & Gamble Health's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Procter & Gamble Health's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Procter & Gamble Health. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Procter & Gamble Health's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Procter & Gamble Health Margin History

Procter & Gamble Health Gross marginProcter & Gamble Health Profit marginProcter & Gamble Health EBIT marginProcter & Gamble Health Profit margin
202465.24 %24.46 %17.46 %
202364.68 %25.12 %18.66 %
202263.13 %22.2 %17.27 %
202165.81 %21.54 %17.53 %
202060.52 %21.37 %18.74 %
201967.09 %20.86 %17.77 %
201860.66 %14.86 %98.79 %
201756.35 %10.57 %13.2 %
201651.62 %9.65 %7.68 %
201547.96 %6.52 %5.71 %
201446.89 %5.34 %4.98 %
201347.24 %8.39 %7.01 %
201252.83 %14.07 %11.41 %
201153.36 %10.97 %10.8 %
201055.22 %13.61 %12.34 %
200952.15 %11.27 %13.84 %
200854.71 %11.3 %16.17 %
200759.12 %19.19 %21.86 %
200657.72 %-0.46 %40.49 %
200554.68 %17.63 %19.87 %

Procter & Gamble Health Stock Sales Revenue, EBIT, Earnings per Share

The Procter & Gamble Health earnings per share therefore indicates how much revenue Procter & Gamble Health has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Procter & Gamble Health earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Procter & Gamble Health's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Procter & Gamble Health’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Procter & Gamble Health's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Procter & Gamble Health Revenue, EBIT and net profit per share

DateProcter & Gamble Health Sales per ShareProcter & Gamble Health EBIT per shareProcter & Gamble Health Earnings per Share
2024693.56 undefined169.68 undefined121.08 undefined
2023740.76 undefined186.06 undefined138.24 undefined
2022655.53 undefined145.53 undefined113.24 undefined
2021593.35 undefined127.82 undefined104 undefined
2020797.59 undefined170.41 undefined149.47 undefined
2019695.6 undefined145.13 undefined123.63 undefined
2018499.41 undefined74.24 undefined493.35 undefined
2017418.53 undefined44.24 undefined55.24 undefined
2016605.76 undefined58.47 undefined46.53 undefined
2015552.65 undefined36.06 undefined31.53 undefined
2014510.29 undefined27.24 undefined25.41 undefined
2013469.29 undefined39.35 undefined32.88 undefined
2012404.29 undefined56.88 undefined46.12 undefined
2011346.82 undefined38.06 undefined37.47 undefined
2010301.24 undefined41 undefined37.18 undefined
2009278.29 undefined31.35 undefined38.53 undefined
2008229.12 undefined25.88 undefined37.06 undefined
2007185.18 undefined35.53 undefined40.47 undefined
2006193.82 undefined-0.88 undefined78.47 undefined
2005233.24 undefined41.12 undefined46.35 undefined

Procter & Gamble Health business model

Procter & Gamble Health Ltd. is a leading company in the health and hygiene products industry. The company was founded in 1837 by William Procter and James Gamble in Cincinnati, Ohio. Since then, the company has undergone incredible development and is now a global corporation with more than 95,000 employees and an annual revenue of nearly $70 billion. The business model of Procter & Gamble Health Ltd. is focused on providing customers with high-quality products at an affordable price. The company operates in various areas, including household products, health products, beauty products, and hygiene products. The different divisions of Procter & Gamble Health Ltd. include the following areas: Household products: Brands like Ariel, Ace, and Lenor are among the most well-known offerings from Procter & Gamble Health. The company is also active in the textile care category and offers various products such as the brand Downy. Health products: The company's health products focus on oral and dental care, as well as pain relief and digestive aids. Brands like Oral-B and Vick are among the most well-known in the portfolio. Beauty products: Procter & Gamble Health offers a wide range of beauty products such as shampoo, conditioner, and hair dye. Herbal Essences, Pantene, and Wella are among the most well-known brands in this area. Hygiene products: The company offers products such as toilet paper, diapers, and cleaning agents. Pampers, Charmin, and Swiffer are among the most well-known brands. Procter & Gamble Health Ltd. has a very extensive product portfolio, which also includes brands like Always, Old Spice, and Gillette. Procter & Gamble Health is an innovative company that continuously offers its customers new and improved products. An example of this is the development of Tide Pods, a novel way to wash laundry that is packaged in a completely soluble shell. In addition to continuous product development, the company also places great importance on sustainability and social responsibility. Procter & Gamble Health actively engages in environmental protection and advocates for the improvement of working conditions and quality of life for people worldwide. In summary, Procter & Gamble Health Ltd. is a successful company that enjoys an excellent reputation due to its innovative strength, extensive product range, and commitment to sustainability and social responsibility. Procter & Gamble Health is one of the most popular companies on Eulerpool.com.

Procter & Gamble Health SWOT Analysis

Strengths

Procter & Gamble Health Ltd benefits from several key strengths:

  • Strong brand reputation and recognition
  • Wide portfolio of well-established and trusted products
  • Extensive global distribution network
  • Strong financial position and resources for research and development
  • Skilled and experienced workforce

Weaknesses

Despite its strengths, Procter & Gamble Health Ltd also faces certain weaknesses:

  • Dependency on a limited number of product categories
  • Reliance on key retailers for sales distribution
  • Vulnerability to changing consumer preferences and trends
  • High competition in the healthcare industry
  • Complex regulations and compliance requirements

Opportunities

Procter & Gamble Health Ltd can capitalize on the following opportunities:

  • Expanding into emerging markets with growing healthcare needs
  • Developing new innovative products to meet evolving consumer demands
  • Acquiring or partnering with complementary healthcare companies
  • Utilizing digital platforms for efficient marketing and customer engagement
  • Increasing focus on preventive healthcare and wellness trends

Threats

Procter & Gamble Health Ltd should be wary of the following threats:

  • Influence of counterfeit products affecting trust in the brand
  • Stringent regulations and compliance challenges
  • Increasing competition from both established and new market players
  • Economic uncertainties and fluctuating exchange rates
  • Emergence of alternative healthcare solutions
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Procter & Gamble Health Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Procter & Gamble Health historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Procter & Gamble Health shares outstanding

The number of shares was Procter & Gamble Health in 2023 — This indicates how many shares 16.599 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Procter & Gamble Health earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Procter & Gamble Health's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Procter & Gamble Health’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Procter & Gamble Health's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Procter & Gamble Health dividend history and estimates

In 2023, Procter & Gamble Health paid a dividend amounting to 145 INR. Dividend means that Procter & Gamble Health distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Procter & Gamble Health provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Procter & Gamble Health’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Procter & Gamble Health's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Procter & Gamble Health Dividend History

DateProcter & Gamble Health Dividend
2024110 undefined
2023145 undefined
202252.5 undefined
202190 undefined
2020188 undefined
2019416 undefined
201815 undefined
201711 undefined
20167.5 undefined
20156 undefined
20148.5 undefined
20132.5 undefined
2010115 undefined
200917.5 undefined
200810 undefined
200710 undefined

Procter & Gamble Health dividend payout ratio

In 2023, Procter & Gamble Health had a payout ratio of 86.23%. The payout ratio indicates the percentage of the company's profits that Procter & Gamble Health distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Procter & Gamble Health represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Procter & Gamble Health could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Procter & Gamble Health's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Procter & Gamble Health Payout Ratio History

DateProcter & Gamble Health Payout ratio
202473.04 %
202386.23 %
202246.37 %
202186.54 %
2020125.78 %
2019336.49 %
20183.04 %
201719.92 %
201616.12 %
201519.04 %
201433.45 %
20137.6 %
201286.23 %
201186.23 %
2010309.39 %
200945.43 %
200826.99 %
200724.71 %
200686.23 %
200586.23 %
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Procter & Gamble Health.

Eulerpool ESG Scorecard© for the Procter & Gamble Health stock

Eulerpool World ESG Rating (EESG©)

72/ 100

🌱 Environment

76

👫 Social

99

🏛️ Governance

42

Environment

Scope 1 - Direct Emissions
374
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
374
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees27
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Procter & Gamble Health shareholders

%
Name
Stocks
Change
Date
51.81368 % Procter & Gamble Co8,601,07109/30/2024
4.10206 % Nippon Life India Asset Management Limited680,94209/30/2024
2.61007 % ICICI Prudential Asset Management Co. Ltd.433,271-3,3839/30/2024
2.48633 % Life Insurance Corporation of India412,7316,5439/30/2024
1.89384 % UTI Asset Management Co. Ltd.314,37809/30/2024
1.34003 % The Vanguard Group, Inc.222,4451,9899/30/2024
0.95605 % DSP Investment Managers Pvt. Ltd.158,70409/30/2024
0.71406 % BlackRock Institutional Trust Company, N.A.118,5346939/30/2024
0.58547 % Dimensional Fund Advisors, L.P.97,1882358/31/2024
0.51991 % Sundaram Asset Management Company Limited86,30509/30/2024
1
2
3
4
...
5

Procter & Gamble Health Executives and Management Board

Mr. Milind Thatte

Procter & Gamble Health Managing Director, Executive Director (since 2018)
Compensation 25.18 M

Mr. Lokesh Chandak

Procter & Gamble Health Chief Financial Officer, Additional Executive Director (since 2023)
Compensation 6.94 M

Mr. Suresh Talwar

(86)
Procter & Gamble Health Non-Executive Independent Chairman of the Board (since 1984)
Compensation 2.38 M

Mrs. Rani Jadhav

(75)
Procter & Gamble Health Non-Executive Independent Director
Compensation 2.2 M

Mr. Subramanian Madhavan

Procter & Gamble Health Non-Executive Independent Director
Compensation 2.13 M
1
2

Most common questions regarding Procter & Gamble Health

What values and corporate philosophy does Procter & Gamble Health represent?

Procter & Gamble Health Ltd represents strong values and a corporate philosophy centered around improving lives through innovative healthcare solutions. With a commitment to delivering quality health and wellness products, the company strives to enhance the well-being of individuals and families worldwide. Procter & Gamble Health Ltd emphasizes integrity, excellence, and collaboration in all aspects of its operations. By continuously investing in research and development, the company aims to provide trusted and effective healthcare solutions to meet the diverse needs of consumers. With its customer-centric approach and dedication to advancing healthcare, Procter & Gamble Health Ltd is a leading player in the industry.

In which countries and regions is Procter & Gamble Health primarily present?

Procter & Gamble Health Ltd is primarily present in India.

What significant milestones has the company Procter & Gamble Health achieved?

Procter & Gamble Health Ltd has achieved various significant milestones throughout its history. With a rich legacy spanning decades, the company has successfully established itself as a leader in the healthcare industry. It has consistently delivered innovative and high-quality healthcare solutions, contributing to improved well-being and quality of life for consumers worldwide. Procter & Gamble Health Ltd has continually expanded its product portfolio, ranging from over-the-counter medications and nutritional supplements to personal care products. Additionally, the company has achieved noteworthy financial growth, expanding its market reach and generating substantial value for its shareholders. Procter & Gamble Health Ltd's commitment to excellence and continuous innovation has solidified its position as a trusted and respected name in the healthcare sector.

What is the history and background of the company Procter & Gamble Health?

Procter & Gamble Health Ltd, previously known as Merck Limited, is a leading healthcare company in India. The company has a rich history that dates back to 1967 when it was incorporated as a joint venture between Merck & Co. Inc. (USA) and a local promoter group. Over the years, it has established itself as a trusted name in the pharmaceutical industry, providing a wide range of innovative healthcare solutions. Procter & Gamble Health Ltd focuses on delivering high-quality products in areas such as vitamins, cough drops, and over-the-counter medicines. With its commitment to improving the well-being of consumers, the company continues to play a vital role in shaping the healthcare landscape in India.

Who are the main competitors of Procter & Gamble Health in the market?

The main competitors of Procter & Gamble Health Ltd in the market are Johnson & Johnson, Pfizer Inc., GlaxoSmithKline plc, and Sanofi.

In which industries is Procter & Gamble Health primarily active?

Procter & Gamble Health Ltd is primarily active in the healthcare industry.

What is the business model of Procter & Gamble Health?

The business model of Procter & Gamble Health Ltd revolves around manufacturing and selling a wide range of consumer healthcare products. As a subsidiary of Procter & Gamble Company, it focuses on developing and marketing products that help consumers improve their health and well-being. Procter & Gamble Health Ltd aims to offer innovative pharmaceuticals, over-the-counter medications, and personal care products to meet the needs of its customers. By consistently delivering high-quality and reliable products, the company strives to maintain a strong market presence and generate sustainable revenue growth.

What is the P/E ratio of Procter & Gamble Health 2024?

The Procter & Gamble Health P/E ratio is 46.46.

What is the P/S ratio of Procter & Gamble Health 2024?

The Procter & Gamble Health P/S ratio is 8.11.

What is the Quality Investing of Procter & Gamble Health?

The Quality Investing for Procter & Gamble Health is 7/10.

What is the revenue of Procter & Gamble Health 2024?

The Procter & Gamble Health revenue is 11.51 B INR.

How high is the profit of Procter & Gamble Health 2024?

The Procter & Gamble Health profit is 2.01 B INR.

What is the business model of Procter & Gamble Health

Procter & Gamble Health Ltd is a leading company in the health and personal care industry, offering a wide range of innovative products and solutions. The company offers products in various categories, including baby care, skincare, oral care, and women’s health. Its baby care products include diapers, wet wipes, baby soap, and baby oil. The skincare products include a wide range of items such as moisturizers, body lotions, and cleansers. The oral care products include toothpaste, mouthwash, and dental floss. The women’s health products include feminine hygiene products such as sanitary pads, tampons, and panty liners. Procter & Gamble Health Ltd strives to develop its products based on innovation, quality, and safety. The company invests in research and development to ensure that its products meet the highest quality standards. It also engages in clinical studies to verify the effectiveness and safety of its products. In addition to selling retail products, Procter & Gamble Health Ltd also operates an extensive business in the medical professionals’ sector. The company conducts educational programs for doctors and medical practitioners to improve their understanding of the products and their application. It also collaborates with leading medical institutions to advance research and innovation in the healthcare industry. Procter & Gamble Health Ltd has a strong global presence and operates in more than 180 countries. The company has a strong market position in the major markets of Europe, Americas, Asia, and the Middle East. It also works with leading distribution partners in all regions to ensure that its products are available worldwide. Overall, Procter & Gamble Health Ltd has a successful business model based on the development and provision of innovative health and personal care products. The company is committed to quality and safety and engages in research and development as well as medical education programs to strengthen its position in the industry. With a large global presence and a diverse product portfolio, Procter & Gamble Health Ltd is well-positioned to continue its successful growth and meet the needs of its customers worldwide.

What is the Procter & Gamble Health dividend?

Procter & Gamble Health pays a dividend of 52.5 INR distributed over payouts per year.

How often does Procter & Gamble Health pay dividends?

The dividend cannot currently be calculated for Procter & Gamble Health or the company does not pay out a dividend.

What is the Procter & Gamble Health ISIN?

The ISIN of Procter & Gamble Health is INE199A01012.

What is the Procter & Gamble Health ticker?

The ticker of Procter & Gamble Health is PGHL.NS.

How much dividend does Procter & Gamble Health pay?

Over the past 12 months, Procter & Gamble Health paid a dividend of 110 INR . This corresponds to a dividend yield of about 1.96 %. For the coming 12 months, Procter & Gamble Health is expected to pay a dividend of 110 INR.

What is the dividend yield of Procter & Gamble Health?

The current dividend yield of Procter & Gamble Health is 1.96 %.

When does Procter & Gamble Health pay dividends?

Procter & Gamble Health pays a quarterly dividend. This is distributed in the months of December, December, March, December.

How secure is the dividend of Procter & Gamble Health?

Procter & Gamble Health paid dividends every year for the past 12 years.

What is the dividend of Procter & Gamble Health?

For the upcoming 12 months, dividends amounting to 110 INR are expected. This corresponds to a dividend yield of 1.96 %.

In which sector is Procter & Gamble Health located?

Procter & Gamble Health is assigned to the 'Health' sector.

Wann musste ich die Aktien von Procter & Gamble Health kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Procter & Gamble Health from 12/25/2024 amounting to 60 INR, you needed to have the stock in your portfolio before the ex-date on 11/28/2024.

When did Procter & Gamble Health pay the last dividend?

The last dividend was paid out on 12/25/2024.

What was the dividend of Procter & Gamble Health in the year 2023?

In the year 2023, Procter & Gamble Health distributed 145 INR as dividends.

In which currency does Procter & Gamble Health pay out the dividend?

The dividends of Procter & Gamble Health are distributed in INR.

All fundamentals about Procter & Gamble Health

Our stock analysis for Procter & Gamble Health Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Procter & Gamble Health Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.